CorMedix CRMD Employee Expense — Sales & Marketing
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's employee expense — sales & marketing.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's employee expense — sales & marketing?
- CorMedix (CRMD) reported employee expense — sales & marketing of $5.65M in Q4 2025.
- How has CorMedix's employee expense — sales & marketing changed year-over-year?
- CorMedix's employee expense — sales & marketing increased by 67.6% year-over-year, from $3.37M to $5.65M.
- What is the long-term trend for CorMedix's employee expense — sales & marketing?
- Over 2 years (2023 to 2025), CorMedix's employee expense — sales & marketing has grown at a 197.7% compound annual growth rate (CAGR), from $2.55M to $22.62M.
- What does employee expense — sales & marketing mean?
- This metric tracks the personnel-related expenditures associated with the commercialization, sales force, and marketing efforts for the company's products. It reflects the investment in human resources required to drive market adoption, physician education, and product awareness. Analyzing this expense provides insight into the company's commercial scaling strategy and the efficiency of its go-to-market operations.